TRUA

TruAlt Bioenergy Limited Stock Price

NSEI:TRUALT Community·₹44.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

TRUALT Share Price Performance

₹519.70
-11.25 (-2.12%)
₹519.70
-11.25 (-2.12%)
Price ₹519.70

TRUALT Community Narratives

There are no narratives available yet.

Recent TRUALT News & Updates

TruAlt Bioenergy Limited Key Details

₹19.1b

Revenue

₹12.8b

Cost of Revenue

₹6.3b

Gross Profit

₹4.9b

Other Expenses

₹1.5b

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
17.04
Gross Margin
33.11%
Net Profit Margin
7.66%
Debt/Equity Ratio
201.5%

TruAlt Bioenergy Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Solid track record with imperfect balance sheet.

2 Risks
1 Reward

About TRUALT

Founded
2021
Employees
470
CEO
Vijaykumar Nirani
WebsiteView website
www.trualtbioenergy.com

TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022. TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Indian Market Performance

  • 7 Days: 1.1%
  • 3 Months: -0.1%
  • 1 Year: -4.4%
  • Year to Date: 1.3%
Over the last 7 days, the market has risen 1.1%, driven by gains of 4.3% in the Information Technology sector. In contrast, the market has seen a decline of 4.4% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›